| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $517.2M | +6.8% |
| Cost of Revenue | $10.2M | -6.2% |
| Gross Profit | $507.1M | +7.1% |
| R&D Expense | $361.6M | +51.0% |
| SG&A Expense | $369.1M | -6.8% |
| Operating Income | -$223.6M | -31.2% |
| Pre-tax Income | -$213.4M | -27.4% |
| Income Tax | $2.5M | +621.1% |
| Net Income | -$216.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.8M | -22.1% |
| Accounts Receivable | $62.2M | -3.4% |
| Inventory | $11.6M | -18.0% |
| Current Assets | $507.9M | -17.8% |
| Total Assets | $587.8M | -16.0% |
| Current Liabilities | $125.6M | +30.8% |
| Total Liabilities | $187.4M | +17.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$114.0M | +9.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $73.2M | +203.0% |
| Financing Cash Flow | $8.2M | -54.9% |
| Free Cash Flow | -$114.0M | +10.1% |
| -28.7% |
| EPS (Basic) | -$1.34 | -27.6% |
| EPS (Diluted) | -$1.34 | -27.6% |
| Stockholders' Equity |
| $400.4M |
| -26.0% |